2026
Chaudhury, A., Kongchan, N., … Zhao, N., … Ferreon, J., & Neilson, J. R. (2026). CELF1 is a non-canonical eIF4E binding protein that promotes translation of epithelial-mesenchymal transition effector mRNAs. Nucleic Acids Research, 54(5).
Pedroza, D. A., Yuan, X., … Zhao, N., … Zhang, X., & Rosen, J. M. (2026). Anti-CSF-1R therapy with combined immuno-chemotherapy coordinate an adaptive immune response to eliminate macrophage enriched triple negative breast cancers. Nature Communications, 17(1), 1193.
2025
Zhao, N. (2025). . Science (Working Life).
2024
Xu, L., Peng, F., … Zhao, N., … Rosen, J. R., & Chen, X. (2024). IRE1α silences dsRNA to prevent taxane-induced pyroptosis in triple-negative breast cancer. Cell, 187(25), 7248–7266.
Yuan, X., Hao, X., Chan, H. L., Zhao, N., … Zhang, X., & Rosen, J. M. (2024). CREB-binding protein/P300 bromodomain inhibition reduces neutrophil accumulation and activates antitumor immunity in triple-negative breast cancer. JCI Insight, 9(20), e182621.
2023
Zhao, N., Kabotyanski, E., Saltzman, A., … Perou, C., & Rosen, J. M. (2023). Targeting EIF4A triggers an interferon response to synergize with chemotherapy and suppress triple-negative breast cancer. Journal of Clinical Investigation, 133(24).
2022
Zhao, N., & Rosen, J. M. (2022). Breast cancer heterogeneity through the lens of single-cell analysis and spatial pathologies. Seminars in Cancer Biology, 82, 3–10.
Si, H., Zhao, N., Pedroza, A., Zaske, A. M., Rosen, J. M., Creighton, C. J., & Roarty, K. (2022). Noncanonical Wnt/Ror2 signaling regulates cell–matrix adhesion to prompt directional tumor cell invasion in breast cancer. Molecular Biology of the Cell, 33(11), ar103.
Singh, S., Lee, N., … Zhao, N., … Perou, C. M., Zhang, X., & Rosen, J. M. (2022). Chemotherapy coupled to macrophage inhibition induces T-cell and B-cell infiltration and durable regression in triple-negative breast cancer. Cancer Research, 82(12), 2281–2297.
Xiao, M. H., Lin, Y. F., … Zhao, N., … Zhu, Y., & Fang, J. H. (2022). Downregulation of a mitochondrial micropeptide, MPM, promotes hepatoma metastasis by enhancing mitochondrial complex I activity. Molecular Therapy, 30(2), 714–725.
2021
Zhao, N., Powell, R. T., … Stephan, C. C., & Rosen, J. M. (2021). Morphological screening of mesenchymal mammary tumor organoids to identify drugs that reverse epithelial-mesenchymal transition. Nature Communications, 12(1), 4262.
Janghorban, M., Yang, Y., Zhao, N., Hamor, C., Nguyen, T. M., Zhang, X. H., & Rosen, J. M. (2021). Single cell analysis unveils the role of the tumor immune microenvironment and Notch signaling in dormant minimal residual disease. Cancer Research, 82(5), 885–899.
2020
Xie, C., Zhang, L. Z., … Zhao, N., He, X., & Zhuang, S. M. (2020). A hMTR4-PDIA3P1-miR-125/124-TRAF6 regulatory axis and its function in NF-κB signaling and chemoresistance. Hepatology, 71(5), 1660–1677.
Nguyen, T. M., Kabotyanski, E. B., … Zhao, N., … Li, W., & Rosen, J. M. (2020). The SINEB1 element in the long non-coding RNA Malat1 is necessary for TDP-43 proteostasis. Nucleic Acids Research, 48(5), 2621–2642.
2019
Guo, Z. W., Meng, Y., Xie, C., Zhao, N., … & Wu, Y. S. (2019). Translated long non-coding ribonucleic acid ZFAS1 promotes cancer cell migration by elevating reactive oxygen species production in hepatocellular carcinoma. Frontiers in Genetics, 10, 1111.
Wang, X., Wang, B., Zhao, N., … Huang, S., & Liu, Y. (2019). Pharmacological targeting of BET bromodomains inhibits lens fibrosis via downregulation of MYC expression. Investigative Ophthalmology & Visual Science, 60(14), 4748–4758.
Kim, I. S., Gao, Y., … Zhao, N., … Rosen, J. M., & Zhang, X. H. (2019). Immuno-subtyping of breast cancer reveals distinct myeloid cell profiles and immunotherapy resistance mechanisms. Nature Cell Biology, 21(9), 1113–1126.
Lin, Y. F., Xiao, M. H., … Zhao, N., … Zhu, Y., & Zhuang, S. M. (2019). A novel mitochondrial micropeptide MPM enhances mitochondrial respiratory activity and promotes myogenic differentiation. Cell Death & Disease, 10(7), 528.
Vijay, G. V., Zhao, N., … Rosen, J. M., & Mani, S. A. (2019). GSK3β regulates epithelial-mesenchymal transition and cancer stem cell properties in triple-negative breast cancer. Breast Cancer Research, 21(1), 1–14.
Zhao, N., Peng, F., & Chen, X. (2019). The unfolded protein response in triple-negative breast cancer. In The Unfolded Protein Response in Cancer (pp. 133–161). Humana Press.
2018
Zhao, N., Cao, J., … Lewis, M. T., & Chen, X. (2018). Pharmacological targeting of MYC-regulated IRE1/XBP1 pathway suppresses MYC-driven breast cancer. Journal of Clinical Investigation, 128(4), 1283–1299.
Lu, Y., Cao, J., Napoli, M., Xia, Z., Zhao, N., … McManus, M. T., & Rosen, J. M. (2018). miR-205 regulates basal cell identity and stem cell regenerative potential during mammary reconstitution. Stem Cells, 36(12), 1875–1889.
Wang, R., Fu, T., You, K., Li, S., Zhao, N., Yang, J., & Zhuang, S. M. (2018). Identification of a TGF-β-miR-195 positive feedback loop in hepatocytes and its deregulation in hepatoma cells. FASEB Journal, 32(7), 3936–3945.
2016
Zhao, N., Li, S., Wang, R., Xiao, M., Meng, Y., Zeng, C., Fang, J. H., Yang, J., & Zhuang, S. M. (2016). Expression of microRNA-195 is transactivated by Sp1 but inhibited by histone deacetylase 3 in hepatocellular carcinoma cells. BBA-Gene Regulatory Mechanisms, 1859(7), 933–942.
2014
Zhao, N., Wang, R., Zhou, L., Zhu, Y., Gong, J., & Zhuang, S. M. (2014). MicroRNA-26b suppresses the NF-κB signaling and enhances the chemosensitivity of hepatocellular carcinoma cells by targeting TAK1 and TAB3. Molecular Cancer, 13(1), 1–11.
2013
Wang, R., Zhao, N., Li, S., Fang, J. H., … & Zhuang, S. M. (2013). MicroRNA-195 suppresses angiogenesis and metastasis of hepatocellular carcinoma by inhibiting the expression of VEGF, VAV2, and CDC42. Hepatology, 58(2), 642–653.